Table 2 Univariate analysis of pathological type, Ki67, therapeutic regimen, and prognosis of MPM patients
From: Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients
Variables | Median survival time (month), 95% CI | P value |
|---|---|---|
All patients | 12 (9.7~14.3) | |
History of asbestos exposure | ||
No | 12 (4.6~19.4) | 0.537 |
Yes | 11 (7.8~14.3) | |
T staging | ||
T3 | 12 (9.5~14.5) | 0.023 |
T4 | 6 (4.7~7.3) | |
Pathological type | 0.005 | |
Epithelioid | 12 (10.1~13.9) | |
Sarcomatoid | 5 (2.0~9.8) | |
Ki67 | 0.036 | |
≤10% | 15 (12.1~17.9) | |
>10% | 11 (7.1~14.9) | |
Therapeutic regimen | <0.001 | |
G1 | 6 (3.8~8.2) | |
G2 | 11 (3.7~18.3) | |
G3 | 12 (8.0~16.0) | |
G4 | 24 (20.0~28.0) | |